Evidence map›Paper›PMID 37340341›Full record

ArticleBMC infectious diseases2023

Bacterial shedding and serologic responses following an outbreak of Salmonella Typhi in an endemic cohort.

Peter I Johnston, Patrick Bogue, Angeziwa Chunga Chirambo, Maurice Mbewe, Reenesh Prakash, Vanessa Kandoole-Kabwere, Rebecca Lester, Thomas Darton, Stephen Baker, Melita A Gordon and 1 more

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Environmental health insights · 2026
    Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Peter I JohnstonInstitute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK. pjohnston@mlw.mw.
Patrick BogueMalawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
Angeziwa Chunga ChiramboDepartment of Medical Laboratory Sciences, Kamuzu University of Health Sciences, Blantyre, Malawi.
Maurice MbeweMalawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
Reenesh PrakashMalawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
Vanessa Kandoole-KabwereMalawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
Rebecca LesterMalawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
Thomas DartonDepartment of Infection, Immunity and Cardiovascular Disease, University of Sheffield, South Yorkshire, UK.
Stephen BakerCambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge, UK.
Melita A GordonInstitute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.
James E MeiringMalawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
Malawi-Liverpool-Wellcome Trust Clinical Research Programme · MWUniversity of Liverpool · GBKamuzu University of Health SciencesUniversity of Cambridge · GBUniversity of Sheffield · GB

Funding

Bill and Melinda Gates Foundation OPP-1161352
6 · The paper itself

Abstract

backgroundSalmonella enterica serovar Typhi (Salmonella Typhi) is the cause of typhoid fever. Salmonella Typhi may be transmitted through shedding in the stool, which can continue after recovery from acute illness. Shedding is detected by culturing stool, which is challenging to co-ordinate at scale. We hypothesised that sero-surveillance would direct us to those shedding Salmonella Typhi in stool following a typhoid outbreak.

methodsIn 2016 a typhoid outbreak affected one in four residents of a Nursing School in Malosa, Malawi. The Department of Health asked for assistance to identify nursing students that might spread the outbreak to other health facilities. We measured IgG antibody titres against Vi capsular polysaccharide (anti-Vi IgG) and IgM / IgG antibodies against H:d flagellin (anti-H:d) three and six months after the outbreak. We selected participants in the highest and lowest deciles for anti-Vi IgG titre (measured at visit one) and obtained stool for Salmonella culture and PCR. All participants reported whether they had experienced fever persisting for three days or more during the outbreak (in keeping with the WHO definitions of 'suspected typhoid'). We tested for salmonellae in the Nursing School environment.

resultsWe obtained 320 paired serum samples from 407 residents. We cultured stool from 25 residents with high anti-Vi IgG titres and 24 residents with low titres. We did not recover Salmonella Typhi from stool; four stool samples yielded non-typhoidal salmonellae; one sample produced a positive PCR amplification for a Salmonella Typhi target. Median anti-Vi and anti-H:d IgG titres fell among participants who reported persistent fever. There was a smaller fall in anti-H:d IgG titres among participants who did not report persistent fever. Non-typhoidal salmonellae were identified in water sampled at source and from a kitchen tap.

conclusionHigh titres of anti-Vi IgG did not identify culture-confirmed shedding of Salmonella Typhi. There was a clear serologic signal of recent typhoid exposure in the cohort, represented by waning IgG antibody titres over time. The presence of non-typhoidal salmonellae in drinking water indicates sub-optimal sanitation. Developing methods to detect and treat shedding remains an important priority to complement typhoid conjugate vaccination in efforts to achieve typhoid elimination.

Indexed as

Salmonella typhiTyphoid FeverAntibodies, BacterialBacterial SheddingDisease OutbreaksHumansImmunoglobulin GImmunoglobulin MAntibodies, BacterialImmunoglobulin GImmunoglobulin MOutbreakSalmonella TyphiSero-surveillanceSheddingTyphoid

Identifiers

PMID37340341
PMCPMC10280929
OpenAlexW4381335123

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.